World's Best Scientists 2026 revealed!
Agneta Siegbahn

Agneta Siegbahn

D-Index & Metrics

Medicine

D-Index
100
Citations
42934
World Ranking
8196
National Ranking
164

Overview

Agneta Siegbahn is affiliated with Uppsala University in Sweden and has a primary focus on research within the field of Medicine, with a particular emphasis on Cardiology and Cardiovascular Medicine. Their work spans various subfields including Molecular Biology, Rheumatology, Endocrinology, Diabetes and Metabolism, as well as Surgery.

The scientist's research covers multiple topics related to cardiovascular health and disease. Prominent areas include:

  • Atrial Fibrillation Management and Outcomes
  • Cardiac Fibrosis and Remodeling
  • GDF15 and Related Biomarkers
  • Antiplatelet Therapy and Cardiovascular Diseases
  • S100 Proteins and Annexins
  • Acute Myocardial Infarction Research
  • Heart Failure Treatment and Management

Recent publications by Agneta Siegbahn highlight this broad focus on cardiovascular disease mechanisms and biomarkers. Notable papers include:

  • Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study, 2021, PLoS Medicine
  • Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis, 2020, Cancer Research
  • Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome, 2021, JAMA Cardiology
  • Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation, 2020, Journal of the American Heart Association
  • Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy, 2020, Journal of the American Heart Association

In terms of collaboration, this scientist frequently works with several researchers, showing multiple coauthorships with:

  • Lars Wallentin
  • Johan Lindbäck
  • Ziad Hijazi
  • Christopher B. Granger
  • John H. Alexander

Their research outputs are published predominantly in highly specialized cardiovascular and medical journals. The most frequent venues for their papers include:

  • Journal of the American Heart Association
  • European Heart Journal
  • Circulation
  • Cardiovascular Research
  • Journal of Thrombosis and Haemostasis

The wide range of topics and publication platforms indicate an ongoing contribution to the understanding of cardiovascular disease, vascular biology, and related biomarker discovery.

Best Publications

  • Discovery and refinement of loci associated with lipid levels

    Cristen J. Willer;Ellen M. Schmidt;Sebanti Sengupta;Gina M. Peloso;Gina M. Peloso;Gina M. Peloso

  • Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.

    J Waltenberger;L Claesson-Welsh;A Siegbahn;M Shibuya

  • Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

    Bertil Lindahl;Henrik Toss;Agneta Siegbahn;Per Venge

  • Large-scale association analysis identifies new risk loci for coronary artery disease

    Panos Deloukas;Stavroula Kanoni;Christina Willenborg;Martin Farrall

  • Common variants associated with plasma triglycerides and risk for coronary artery disease

    Ron Do;Cristen J. Willer;Ellen M. Schmidt;Sebanti Sengupta

  • N-Terminal Pro–Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease A Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV Substudy

    Stefan K. James;Bertil Lindahl;Agneta Siegbahn;Mats Stridsberg

  • Low-molecular-weight heparin during instability in coronary artery disease

    L Wallentin;J Ohlsson;E Swahn;E Karlsson

  • Relationship Between Interleukin 6 and Mortality in Patients With Unstable Coronary Artery Disease: Effects of an Early Invasive or Noninvasive Strategy

    Eva Lindmark;Erik Diderholm;Lars Wallentin;Agneta Siegbahn

  • Prognostic Influence of Increased Fibrinogen and C-Reactive Protein Levels in Unstable Coronary Artery Disease

    Henrik Toss;Bertil Lindahl;A Siegbahn;Lars Wallentin

  • Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

    Tomas Jernberg;Christopher D. Payne;Kenneth J. Winters;Christelle Darstein

  • Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial

    Jonas Oldgren;Andrzej Budaj;Christopher B. Granger;Yasser Khder

  • Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease.

    Raffaele De Caterina;Steen Husted;Lars Wallentin;Felicita Andreotti

  • Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation A RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) Trial Analysis

    Ziad Hijazi;Stefan H. Hohnloser;Jonas Oldgren;Ulrika Andersson

  • Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

    Lasse Folkersen;Stefan Gustafsson;Qin Wang;Qin Wang;Daniel Hvidberg Hansen

  • The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

    Ziad Hijazi;Jonas Oldgren;Johan Lindbäck;John H Alexander

  • Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy

    Ziad Hijazi;Jonas Oldgren;Ulrika Andersson;Stuart J. Connolly

  • Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

    Lars Wallentin;Christoph Varenhorst;Stefan James;David Erlinge

  • The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

    Ziad Hijazi;Johan Lindbäck;John H. Alexander;Michael Hanna

  • Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis.

    Peter Blume-Jensen;Lena Claesson-Welsh;Agneta Siegbahn;Krisztina M. Zsebo

  • PDGF alpha- and beta-receptors activate unique and common signal transduction pathways.

    A Eriksson;A Siegbahn;B Westermark;C H Heldin

Frequent Co-Authors

Lars Wallentin
Lars Wallentin Uppsala University
Stefan James
Stefan James Uppsala University
Robert F. Storey
Robert F. Storey University of Sheffield
Christopher B. Granger
Christopher B. Granger Duke University
Renato D. Lopes
Renato D. Lopes Duke University
Richard C. Becker
Richard C. Becker University of Cincinnati
John H. Alexander
John H. Alexander Duke University
Claes Held
Claes Held Uppsala University
Steen Husted
Steen Husted Aarhus University Hospital
Bertil Lindahl
Bertil Lindahl Uppsala University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, there are several flexible online degree options that can accelerate your career in healthcare. For those who want to advance quickly, accelerated dnp programs can help you earn a Doctor of Nursing Practice efficiently, paving the way for leadership roles.

Cost is an important factor for many students. That’s where cheapest dnp programs come in, helping you reach your career goals without a heavy financial burden. For those just starting out, online lpn programs offer a practical, entry-level path into nursing that can be completed quickly and conveniently.

If you already hold a BSN and are looking to specialize, consider bsn to np programs online, which allow you to advance into nurse practitioner roles in high-demand areas such as mental health. These related degrees and career pathways provide diverse, accessible routes for those passionate about healthcare to make a difference.

Best Scientists Citing Agneta Siegbahn

Trending Scientists

Recently Published Articles